Back to Search
Start Over
ASPI: a public–private partnership to develop treatments for autism
ASPI: a public–private partnership to develop treatments for autism
- Source :
- Nature Reviews Drug Discovery. 19:219-220
- Publication Year :
- 2020
- Publisher :
- Springer Science and Business Media LLC, 2020.
-
Abstract
- Numerous potential therapeutic targets are being investigated in autism spectrum disorder (ASD). Here, we discuss a platform trial approach for designing proof-of-concept (POC) clinical studies of ASD — via the Autism Spectrum POC Initiative (ASPI) — that can be conducted through a public–private partnership with the aim of finding effective treatments in the most expeditious manner. Numerous potential therapeutic targets are being investigated in autism spectrum disorder (ASD). Here, we discuss a platform trial approach for designing proof-of-concept (POC) clinical studies of ASD — via the Autism Spectrum POC Initiative (ASPI) — that can be conducted through a public–private partnership with the aim of finding effective treatments in the most expeditious manner.
- Subjects :
- 0301 basic medicine
Pharmacology
medicine.medical_specialty
General Medicine
medicine.disease
behavioral disciplines and activities
03 medical and health sciences
Public–private partnership
030104 developmental biology
0302 clinical medicine
Autism spectrum disorder
030220 oncology & carcinogenesis
General partnership
mental disorders
Drug Discovery
medicine
Autism
Psychiatry
Psychology
Subjects
Details
- ISSN :
- 14741784 and 14741776
- Volume :
- 19
- Database :
- OpenAIRE
- Journal :
- Nature Reviews Drug Discovery
- Accession number :
- edsair.doi...........c8d39e15c726a948d9d8de9678498a85
- Full Text :
- https://doi.org/10.1038/d41573-020-00012-4